Used in pharmaceutical research as a key intermediate in the synthesis of protease inhibitors, particularly in the development of antiviral agents. Its structure supports selective binding to enzyme active sites, making it valuable in designing drugs targeting viral replication. The compound's chiral centers and functional groups allow for precise molecular interactions, enhancing drug efficacy and stability. It is also employed in studies focused on improving bioavailability and metabolic resistance in peptide-based therapeutics.